On February 1, 2024 UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, reported that it will present at the following investor conferences in February (Press release, UroGen Pharma, FEB 1, 2024, View Source [SID1234639794]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Guggenheim 6th Annual Biotechnology Conference – February 7-8, 2024
Fireside Chat: February 8, 2024 at 11:00 AM ET
Format: 1×1 meetings
Location: New York, NY
Webcast Link: View Source

Oppenheimer 34th Annual Healthcare Life Sciences Conference – February 13-14, 2024
Presentation: February 13, 2024 at 12:00 PM ET
Format: Virtual
Webcast Link: View Source;page=urgn&url=View Source

A webcast from both conferences will also be available via the Investors section of UroGen’s website, www.urogen.com. A replay of the webcast will be available for approximately 90 days.